Bridgewater Associates LP Purchases New Holdings in Integer Holdings Co. (NYSE:ITGR)

Bridgewater Associates LP purchased a new stake in Integer Holdings Co. (NYSE:ITGR) in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 33,554 shares of the medical equipment provider’s stock, valued at approximately $3,161,000. Bridgewater Associates LP owned approximately 0.10% of Integer as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also recently modified their holdings of ITGR. Franklin Resources Inc. lifted its position in shares of Integer by 12.6% in the 1st quarter. Franklin Resources Inc. now owns 2,149,013 shares of the medical equipment provider’s stock valued at $197,923,000 after acquiring an additional 241,228 shares in the last quarter. Aureus Asset Management LLC purchased a new stake in Integer in the 1st quarter worth approximately $21,209,000. JPMorgan Chase & Co. lifted its position in Integer by 61.7% in the 2nd quarter. JPMorgan Chase & Co. now owns 240,590 shares of the medical equipment provider’s stock worth $22,663,000 after buying an additional 91,795 shares in the last quarter. Ameriprise Financial Inc. lifted its position in Integer by 24.4% in the 1st quarter. Ameriprise Financial Inc. now owns 394,098 shares of the medical equipment provider’s stock worth $36,370,000 after buying an additional 77,184 shares in the last quarter. Finally, New York State Common Retirement Fund lifted its position in Integer by 52.8% in the 2nd quarter. New York State Common Retirement Fund now owns 123,330 shares of the medical equipment provider’s stock worth $11,618,000 after buying an additional 42,615 shares in the last quarter. Institutional investors and hedge funds own 98.43% of the company’s stock.

In other Integer news, insider Carter Houghton sold 2,500 shares of the business’s stock in a transaction dated Wednesday, August 4th. The shares were sold at an average price of $93.55, for a total value of $233,875.00. Following the completion of the transaction, the insider now directly owns 2,708 shares of the company’s stock, valued at $253,333.40. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, SVP Anthony W. Borowicz sold 1,100 shares of the business’s stock in a transaction dated Wednesday, August 11th. The stock was sold at an average price of $90.22, for a total transaction of $99,242.00. Following the completion of the transaction, the senior vice president now directly owns 21,333 shares of the company’s stock, valued at $1,924,663.26. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 16,772 shares of company stock worth $1,596,670. 2.08% of the stock is owned by company insiders.

NYSE:ITGR opened at $87.34 on Thursday. The company has a current ratio of 2.65, a quick ratio of 1.75 and a debt-to-equity ratio of 0.48. The firm has a market capitalization of $2.88 billion, a PE ratio of 29.81 and a beta of 1.42. The firm’s fifty day simple moving average is $93.30 and its 200 day simple moving average is $92.66. Integer Holdings Co. has a 1 year low of $54.37 and a 1 year high of $101.61.

Integer (NYSE:ITGR) last posted its quarterly earnings results on Thursday, July 29th. The medical equipment provider reported $1.07 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.91 by $0.16. The company had revenue of $312.02 million for the quarter, compared to analyst estimates of $292.50 million. Integer had a net margin of 8.73% and a return on equity of 8.46%. As a group, analysts anticipate that Integer Holdings Co. will post 3.98 EPS for the current fiscal year.

A number of equities research analysts have issued reports on the stock. Argus increased their target price on shares of Integer from $100.00 to $105.00 and gave the stock a “buy” rating in a research report on Monday, September 13th. KeyCorp raised their price target on shares of Integer from $105.00 to $107.00 and gave the company an “overweight” rating in a report on Friday, July 30th. Finally, Zacks Investment Research upgraded shares of Integer from a “hold” rating to a “buy” rating and set a $98.00 price target on the stock in a report on Wednesday, June 23rd.

Integer Profile

Integer Holdings Corp. engages in the manufacture and development of medical devices and components. It operates through the Medical and Non-Medical segments. The Medical segment includes the cardio and vascular, cardiac and neuromodulation, surgical, orthopedics, and portable medical product lines. The Non-Medical segment comprises customized battery power and management systems, charging and docking stations, and power supplies.

Featured Article: Gross Domestic Product (GDP)

Want to see what other hedge funds are holding ITGR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Integer Holdings Co. (NYSE:ITGR).

Institutional Ownership by Quarter for Integer (NYSE:ITGR)

Receive News & Ratings for Integer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integer and related companies with MarketBeat.com's FREE daily email newsletter.